Dietary interaction of high fat and marginal copper deficiency on cardiac contractile function

Obesity

Volumn 15, Issue 5, 2007, Pages 1242-1257

  Relling, David P ^a   Esberg, Lucy B ^a   Johnson, W Thomas ^b   Murphy, Eric J ^a   Carlson, Edward C ^a   Lukaski, Henry C ^b   Saari, Jack T ^b   Ren, Jun ^a,c  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^c UNIVERSITY OF WYOMING   (United States)

Author keywords

Cardiac dysfunction; Copper deficient diet; Dietary intake; High fat diet

Indexed keywords

COPPER;

ANIMAL; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; DRUG EFFECT; FAT INTAKE; GLUCOSE BLOOD LEVEL; HEART CONTRACTION; HEART DISEASE; MAGNESIUM DEFICIENCY; MALE; METABOLISM; PHYSIOLOGY; RAT;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; COPPER; DIETARY FATS; HEART DISEASES; MAGNESIUM DEFICIENCY; MALE; MODELS, ANIMAL; MYOCARDIAL CONTRACTION; RATS;

RATTUS;

EID: 34250629119     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.146     Document Type: Article

References (70)

1. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation. 2000;102:3137-47.
2. Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res. 1998;39:89-105.
3. Mensah GA, Mokdad AH, Ford E, et al. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiol Clin. 2004;22:485-504.
4. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-55.
5. de Divitlis O, Fazio S, Petitto M, Maddalena G, Contaldo F, Manclni M. Obesity and cardiac function. Circulation. 1981;64:477-82.
6. Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA. 2000;97:1784-9.
7. Li SY, Yang X, Ceylan-Isik AF, Du M, Sreejayan N, Ren J. Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch. Diabetologia. 2006;49:1434-46.
8. Ren J, Walsh MF, Jefferson L, et al. Basal and ethanol-induced cardiac contractile response in lean and obese Zucker rat hearts. J Biomed Sci. 2000;7:390-400.
9. Ren J, Sowers JR, Walsh MF, Brown RA. Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. Am J Physiol Heart Circ Physiol. 2000;279:H1708-14.
10. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension. 2001;37:554-60.
11. Sowers JR. Obesity and cardiovascular disease. Clin Chem. 1998;44:1821-5.
12. Ren J, Walsh MF, Hamaty M, Sowers JR, Brown RA. Augmentation of the inotropic response to insulin in diabetic rat hearts. Life Sci. 1999;65:369-80.
13. Ren J, Walsh MF, Hamaty M, Sowers JR, Brown RA. Altered inotropic response to IGF-I in diabetic rat heart: influence of intracellular Ca2+ and NO. Am J Physiol. 1998;275:H823-30.
14. Relling DP, Esberg LB, Fang CX, et al. High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis. J Hypertens. 2006;24:549-61.
15. Unger RH. Lipotoxic diseases. Annu Rev Med. 2002;53:319-36.
16. Hansen HS, Jensen B. Essential function of linoleic acid esterified in acylglucosylceramide and acylceramide in maintaining the epidermal water permeability barrier. Evidence from feeding studies with oleate, linoleate, arachidonate, columbinate and alpha-linolenate. Biochim Biophys Acta. 1985;834:357-63.
17. Ghayour-Mobarhan M, Taylor A, New SA, Lamb DJ, Ferns GA. Determinants of serum copper, zinc and selenium in healthy subjects. Ann Clin Biochem. 2005;42:364-75.
18. Klevay LM. Heart failure improvement from a supplement containing copper. Eur Heart J. 2006;27:117-8.
19. Klevay LM. Cardiovascular disease from copper deficiency - a history. J Nutr. 2000;130(2S Suppl):489S-92S.
20. Kennedy ML, Failla ML, Smith JC Jr. Influence of genetic obesity on tissue concentrations of zinc, copper, manganese and iron in mice. J Nutr. 1986;116:1432-41.
21. Donaldson DL, Smith CC, Koh E. Effects of obesity and diabetes on tissue zinc and copper concentrations in the Zucker rat. Nutr Res (NY). 1987;7:393-9.
22. Serfass RE, Park KE, Kaplan ML. Developmental changes of selected minerals in Zucker rats. Proc Soc Exp Biol Med. 1988;189:229-39.
23. Zargar AH, Shah NA, Masoodi SR, et al. Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgrad Med J. 1998;74:665-8.
24. Saari JT, Schuschke DA. Cardiovascular effects of dietary copper deficiency. Biofactors. 1999;10:359-75.
25. Jenkins JE, Medeiros DM. Diets containing corn oil, coconut oil and cholesterol alter ventricular hypertrophy, dilatation and function in hearts of rats fed copper-deficient diets. J Nutr. 1993;123:1150-60.
26. Lear PM, Heller LJ, Prohaska JR. Cardiac hypertrophy in copper-deficient rats is not attenuated by angiotensin II receptor antagonist L-158,809. Proc Soc Exp Biol Med. 1996;212:284-92.
27. Prohaska JR, Heller LJ. Mechanical properties of the copper-deficient rat heart. J Nutr. 1982;112:2142-50.
28. Kang YJ, Zhou ZX, Wu H, Wang GW, Saari JT, Klein JB. Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab Invest. 2000;80:745-57.
29. Fernandez-Lopez JA, Esteve M, Rafecas I, Remesar X, Alemany M. Management of dietary essential metals (iron, copper, zinc, chromium and manganese) by Wistar and Zucker obese rats fed a self-selected high-energy diet. Biometals. 1994;7:117-29.
30. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-51.
31. Reeves PG, Rossow KL, Lindlauf J. Development and testing of the AIN-93 purified diets for rodents: results on growth, kidney calcification and bone mineralization in rats and mice. J Nutr. 1993;123:1923-31.
32. Hall CB, Lukaski HC, Marchello MJ. Estimation of rat body composition using tetrapolar bioelectrical impedance analysis. Nutr Rep Int. 1989;39:627-33.
33. Fang CX, Dong F, Ren BH, Epstein PN, Ren J. Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance: role of Akt phosphorylation, PTB1B, PPARgamma and c-Jun. Diabetologia. 2005;48:2412-21.
34. Wold LE, Relling DP, Duan J, Norby FL, Ren J. Abrogated leptin-induced cardiac contractile response in ventricular myocytes under spontaneous hypertension: role of Jak/STAT pathway. Hypertension. 2002;39:69-74.
35. Dong F, Esberg LB, Roughead ZK, Ren J, Saari JT. Increased contractility of cardiomyocytes from copper-deficient rats is associated with upregulation of cardiac IGF-I receptor. Am J Physiol Heart Circ Physiol. 2005;289:H78-84.
36. Ren J, Porter JE, Wold LE, Aberle NS, Muralikrishnan D, Haselton JR. Depressed contractile function and adrenergic responsiveness of cardiac myocytes in an experimental model of Parkinson disease, the MPTP-treated mouse. Neurobiol Aging. 2004;25:131-8.
37. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
38. Dobrowsky RT, Kolesnick RN. Analysis of sphingomyelin and ceramide levels and the enzymes regulating their metabolism in response to cell stress. Methods Cell Biol. 2001;66:135-65.
39. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497-509.
40. Brockerhoff H. Determination of the positional distribution of fatty acids in glycerolipids. Methods Enzymol 1975;35:315-25.
41. Prows DR, Murphy EJ, Moncecchi D, Schroeder F. Intestinal fatty acid-binding protein expression stimulates fibroblast fatty acid esterification. Chem Phys Lipids. 1996;84:47-56.
42. Gavrieli Y, Sherman Y, Ben Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
43. Ren J, Wold LE, Natavio M, Ren BH, Hannigan JH, Brown RA. Influence of prenatal alcohol exposure on myocardial contractile function in adult rat hearts: role of intracellular calcium and apoptosis. Alcohol Alcohol. 2002;37:30-7.
44. Chirico S. High-performance liquid chromatography-based thiobarbituric acid tests. Methods Enzymol. 1994;233:314-8.
45. Yarian CS, Rebrin I, Sohal RS. Aconitase and ATP synthase are targets of malondialdehyde modification and undergo an age-related decrease in activity in mouse heart mitochondria. Biochem Biophys Res Commun. 2005;330:151-6.
46. Davies NT, Lawrence CB, Mills CF. Studies on the effects of copper deficiency on rat liver mitochondria. II. Effects on oxidative phosphorylation. Biochim Biophys Acta. 1985;809:362-8.
47. Johnson WT, Demars LC. Increased heme oxygenase-1 expression during copper deficiency in rats results from increased mitochondrial generation of hydrogen peroxide. J Nutr. 2004;134:1328-33.
48. Sarti C, Gallagher J. The metabolic syndrome: prevalence, CHD risk, and treatment. J Diabetes Complications. 2006;20:121-32.
49. Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension. 2000;35:1009-15.
50. Norby FL, Wold LE, Duan J, Hintz KK, Ren J. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab. 2002;283:E658-66.
51. Roberts CK, Vaziri ND, Wang XQ, Barnard RJ. Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet. Hypertension. 2000;36:423-9.
52. Bjorbaek C, Uotani S, da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem. 1997;272:32686-95.
53. Saari JT. Copper deficiency and cardiovascular disease: role of peroxidation, glycation, and nitration. Can J Physiol Pharmacol. 2000;78:848-55.
54. Mao S, Medeiros DM, Hamlin RL. Marginal copper and high fat diet produce alterations in electrocardiograms and cardiac ultrastructure in male rats. Nutrition. 1999;15:890-8.
55. Saari JT. Renal copper as an index of copper status in marginal deficiency. Biol Trace Elem Res. 2002;86:237-47.
56. Wlldman RE, Hopkins R, Failla ML, Medeiros DM. Marginal copper-restricted diets produce altered cardiac ultrastructure in the rat. Proc Soc Exp Biol Med. 1995;210:43-9.
57. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med. 2003;115(Suppl 8A):37S-41S.
58. Ren J, Ceylan-Isik AF. Diabetic cardiomyopathy: do women differ from men? Endocrine. 2004;25:73-83.
59. Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem. 1998;273:32487-90.
60. Houser SR, Piacentino V III, Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol. 2000;32:1595-607.
61. Duan J, Zhang HY, Adkins SD, et al. Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA. Am J Physiol Endocrinol Metab. 2003;284:E366-76.
62. Huang B, Wang S, Qin D, Boutjdir M, El Sherif N. Diminished basal phosphorylation level of phospholamban in the postinfarction remodeled rat ventricle: role of beta-adrenergic pathway, G(i) protein, phosphodiesterase, and phosphatases. Circ Rea. 1999;85:848-55.
63. Lin WH, Chen MD, Wang CC, Lin PY. Dietary copper supplementation increases the catecholamine levels in genetically obese (ob/ob) mice. Biol Trace Elem Res. 1995;50:243-7.
64. Ghibaudi L, Cook J, Farley C, van Heek M, Hwa JJ. Fat intake affects adiposity, comorbidity factors, and energy metabolism of Sprague-Dawley rats. Obes Res. 2002;10:956-63.
65. Zhang DX, Fryer RM, Hsu AK, et al. Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats. Basic Res Cardiol. 2001;96:267-74.
66. Franzen R, Pfeilschifter J, Huwiler A. Nitric oxide induces neutral ceramidase degradation by the ubiquitin/proteasome complex in renal mesangial cell cultures. FEBS Lett. 2002;532:441-4.
67. Sabbadini RA, Betto R, Teresi A, Fachechi-Cassano G, Salviati G. The effects of sphingosine on sarcoplasmic reticulum membrane calcium release. J Biol Chem. 1992;267:15475-84.
68. 2+ levels. Inhibitory actions of sphingosine on Ca2+ transients and L-type Ca2+ channel conductance. Circ Res. 1994;75:981-9.
69. Oral H, Dorn GW, Mann DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factoralpha in the adult mammalian cardiac myocyte. J Biol Chem. 1997;272:4836-42.
70. Relling DP, Hintz KK, Ren J. Acute exposure of ceramide enhances cardiac contractile function in isolated ventricular myocytes. Br J Pharmacol. 2003;140:1163-8.